سعر بريموكوما 0.2% 2025

Brimocoma 0.2% brimonidine tartrate eye drops 5 ml (Global Advanced Pharmaceuticals). Antiglaucoma ophthalmic solution.

• Reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.Population: Adults (ophthalmic use)DailyMed / FDA

• Common (approx. 5–20%): allergic conjunctivitis, burning, conjunctival folliculosis/hyperemia, eye pruritus, hypertension, ocular allergic reaction, oral dryness, visual disturbance.International label, equivalent formulation · DailyMed / FDA

• Neonates and infants (pediatric patients younger than 2 years old).International label, equivalent formulation · DailyMed / FDA
• Hypersensitivity to brimonidine or any component of the formulation.International label, equivalent formulation · DailyMed / FDA

• May potentiate syndromes associated with vascular insufficiency (depression, cerebral/coronary insufficiency, Raynaud’s, orthostatic hypotension, thromboangiitis obliterans).International label, equivalent formulation · DailyMed / FDA
• Use caution in severe cardiovascular disease. Reports of bacterial keratitis with contaminated multi-dose ophthalmic containers.International label, equivalent formulation · DailyMed / FDA

• Antihypertensives / cardiac glycosidesModerateBrimonidine may reduce blood pressure; caution with antihypertensives or cardiac glycosides.DailyMed / FDA
• CNS depressantsModeratePossible additive/potentiating effect with alcohol, barbiturates, opiates, sedatives, or anesthetics.DailyMed / FDA
• MAO inhibitorsMajorMAO inhibitors may interfere with brimonidine metabolism and increase systemic effects such as hypotension.DailyMed / FDA

• No adequate well-controlled studies in pregnant women; limited human data insufficient to establish risk. Use only if potential benefit justifies potential fetal risk.International label, equivalent formulation · DailyMed / FDA
• Not recommended during lactation because of potential for serious adverse reactions in nursing infants (CNS depression/apnea). Unknown if excreted in human milk; excreted in animal milk.International label, equivalent formulation · DailyMed / FDA

• Brimonidine tartrate: Alpha-2 agonist that lowers IOP by reducing aqueous humor production and increasing uveoscleral outflow; topically causes dermal vasoconstriction.